A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines

British Journal of Cancer

Volumn 80, Issue 10, 1999, Pages 1518-1524

  Chiarotto, J A ^a   Hill, R P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cervical cancer; Gene up regulation; Hypoxia; Oxygen concentration; VEGF

Indexed keywords

MESSENGER RNA; OXYGEN; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; METASTASIS; MICHAELIS CONSTANT; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY; SOLID TUMOR; UTERINE CERVIX CANCER;

CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; FEMALE; HALF-LIFE; HUMANS; LYMPHOKINES; OXYGEN; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033038190     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690555     Document Type: Article

References (55)

1. Berger DP, Herbstrilt L, Dengler WA, Marme D, Mertelsmann R and Fiebig HH (1995) Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies. Ann Oncol 6: 817-825
2. Boag JW (1970) Cell respiration as a function of oxygen tension. Int J Radiat Biol Relat Stud Phys Chem Med 18: 475-478
3. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR and Dewhirst MW (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941-943
4. Brown JM and Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416
5. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AI, Dvorak HF, Senger DR, Connolly JL and Schnitt SJ (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26: 86-91
6. Bunn HP and Poyton RO (1996) Oxygen sensing and molecular adaptation to hypoxia, Physiol Rev 76: 839-885
7. Chapman JD, Dugle DL, Reuvers AP, Meeker BE and Borsa J (1974) Studies on the radiosensitizing effect of oxygen in Chinese hamster cells. Int J Radiat Biol 26: 383-389
8. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo K-T, Manseau EJ and Dvorak HF (1996) Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis Cancer Res 56: 172-181
9. Danielsen T and Rofstad EK (1998) Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. Forty-sixth Annual Meeting of the Radiation Research Society 168
10. Dewhirst MW (1998) Concepts of oxygen transport at the microcirculatory level. Semin Radiat Oncol 8: 143-150
11. Dvorak HF, Brown LF, Detmar M and Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039
12. Fontini G, Vignati S, Lucchi M, Mussi A, Calcinai A, Boldrini L, Chine S, Silvestri V, Angeletti CA, Basolo F and Bevilacqua G (1997) Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br J Cancer 75: 1295-1301
13. Forsythe JA, Jiang B-H, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor I. Mol Cell Biol 16: 4604-4613
14. Fyles AW, Milosevic M, Wong R, Kavanagh M-C, Pintilie M, Chapman W, Levin W, Manchul L, Keane TJ and Hill RP (1998) Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48: 149-156
15. Gatenby RA, Kessler HB, Rosenbloom JS, Coia LR, Moldofsky PJ, Hartz WH and Broder GJ (1988) Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biot Phys 14: 831-838
16. Goldman CK, Kendall RL, Cabrera G, Soroceano L, Heike Y, Gillespie GY, Siegal GP, Mao X, Bett AJ, Huckle WR, Thomas KA and Curiel DT (1998) Paracrine expression of a native soluble vascular enduthelial growth factor receptor inhibits minor growth, metastasis, and mortality rale. Proc Natl Acad Sci USA 95: 8795-8800
17. Guidi AJ, Abu-Jawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF and Brown LF (1995) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 87: 1237-1244
18. Helmlinger G and Jain R (1998) Private communication
19. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26: 45-50
20. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U and Vaupel P (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515
21. Hockel M and Vaupel P (1998) The prognostic significance of hypoxia in cervical cancer: a radiobiological or tumor biological phenomenon? In: Blood Perfusion and Microenvironment of Human Tumors. Molls M and Vaupel P (eds), pp. 73-79. Springer: New York
22. Jang A and Hill RP (1997) An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin Exp Metastas 15: 469-483
23. 2 tersion. Am J Physiol 271 : C1172-C1180
24. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844
25. Koch CJ (1984) A thin-film culturing technique allowing rapid gas-liquid equilibration (6 sec) with no toxicity to mammalian cells. Radiat Res 97: 434-442
26. Koch CJ, Evans SM and Lord EM (1995) Oxygen dependence of cellular uptake of EF5 [2-(nitro-1H-imidazole 1-y1) N-(2,2,3,3,3-pentafluoropropyl)acetamide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Br J Cancer 72: 869-874
27. Kondo S, Asano M and Suzuki H (1993) Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 194: 1234-1241
28. Laborda J (1991) 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19: 3998
29. Leith JT and Michelson S (1995) Secretion rates and levels of vascular endothelial growth factor in clones of HCT-8 human colon tumour cells as a function of oxygen concentration. Cell Prolif 28: 415-430
30. Levy AP, Levy NS and Goldberg MA (1996) Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271: 2746-2753
31. Levy NS, Chung S, Furneaux H and Levy AP (1998) Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273: 6417-6423
32. Marshall RS, Koch CJ and Rauth AM (1986) Measurement of low levels of oxygen and their effect on respiration in cell suspensions maintained in an open system. Radiat Res 108: 91-101
33. Minchenko A, Bauer T, Salceda S and Caro J (1994) Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo, Lab Invest 71: 374-379
34. Mukhapadhyay D, Tsiokas L, Zhou X-MZ, Foster D, Brugge JS and Sukhatme VP (1995) Hypoxic induction of human vascular endothelial growth factor expression through c-Sre activation. Nature 375: 577-581
35. Nordsmark M, Overgaard M and Overgaard J (1996) Pretreatment oxygenation predicts radiation response in advance squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31-39
36. Plate KH, Brier G, Weich HA, Mennel HD and Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59: 520-529
37. Raleigh JA, Calkins-Adams DP, Rinker LH, Ballenger CA, Weissler MC, Fowler WC, Novotny DB, WeisslEr MC and Varia MA (1998) Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinoma using pimonidazole as a hypoxia marker. Cancer Res 58: 3765-3768
38. Raleigh JA, Dewhirst MW and Thrall DE (1996) Measuring tumor hypoxia. Semin Radiat Oncol 6: 37-45
39. Roberts WG and Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108: 2369-2379
40. Senger DR, Van De Water L, Brown LF, Nagy JA, Yeo K-T, Yeo T-K, Berse B, Jackman RW, Dvorak AM and Dvorak HF (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metast Rev 12: 303-324
41. Shweiki D, Itin A, Soffer D and Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-848.
42. Shweiki D, Neeman M, Itin A and Keshet E (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogeneis. Proc Natl Acad Sci USA 92: 768-772
43. Slaven P, Heikkila P and Joensuu H (1997) Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer 76: 930-934
44. Stein I, Neeman M, Shweiki D, Itin A and Keshet E (1995) Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and co-regulation with other ischemia-induced genes. Mol Cel Biol 15: 5363-5368
45. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM (1995) Expression of vascular endothial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968
46. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC and Abraham JA (1991) The human gene for vascular endothelial growth factor. J Biol Chem 266: 11947-11954
47. Toi M, Inada K, Suzuki H and Tominaga T (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36: 193-204
48. Vaupel P and Hockel M (1998) Oxygenation of human minors In: Blood Perfusion and Microenvironment of Human Tumors Molls, M and Vaupel F (eds), pp. 63-72. Springer: New York
49. Vaupel P, Kallinowski F and Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465
50. Vukovic V, Hill RP, Rauth AM and Hedley DW (1998) Effects of BSO on NPSH profiles, DNA single strand breaks and cell survival in ME180 and SiHa cells irradiated at intermediate oxygen concentrations. Radiat Res (submitted)
51. Waleh NS, Brody MD, Knapp MA, Mendonca HL, Lord EM, Koch CJ, Laderoute KR and Sutherland RM (1995) Mapping of the vascular endothelial growth factor-producing hypoxic cell in multicellular tumor spheroids using a hypoxia specific marker. Cancer Res 55: 6222-6226
52. Whillans DW and Rauth AM (1980) An experimental and analytical study of oxygen depletion in stirred cell suspensions. Radiat Res 84: 97-114.
53. Xie K, Haung S, Xu L and Fidler IJ (1998) Molecular mechanisms for the regulation of vascular endothelial growth factor expression by extracellular and intracellular pH. Proceedings of the 89th Annual Meeting of American Association Cancer Research 39: 378.
54. Young SD, Marshall RS and Hill RP (1988) Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 85: 9533-9537
55. Zinn K, DiMaio D and Maniatis T (1983) Identification of two distinct regulatory regions adjacent to the human β-interferon gene. Cell 34: 865-879